The Primary Aldosteronism Screening to Treatment Pathway (PASTP) is part of a quality improvement and research initiative designed to understand and reduce barriers to screening and treatment for primary aldosteronism.

Primary aldosteronism is a very common but under-diagnosed and under-treated cause of hypertension, cardiovascular disease and chronic kidney disease.

Here we provide our streamlined screening to treatment algorithm which is based on the [2025 Endocrine Society Clinical Practice Guideline for Primary Aldosteronism](https://doi.org/10.1210/clinem/dgaf284).

## Contact Us

For more information please email <philip.knapp@bmc.org>.

## Algorithm

![primary aldosteronism algorithm](/sites/default/files/inline-images/image_53.png) 

 [Download the Detailed Algorithm (PDF)](https://www.bmc.org/sites/default/files/2026-10/Primary%20Aldosteronism%20Screening%20to%20Treatment%20Pathway%20-9-2026.pdf)